Roskilde, Denmark · Founded 2019 · Privately Held (backing)
Developer of a medical device designed to replace the standard injection system of medicines. Biograil is based in Roskilde, Denmark and was founded in 2019. Its last reported valuation was $31.5 million in Dec 2025. It has raised $21.1 million.
Last reported valuation
$31.5M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
—
Cap table — not yet on record
Biograil's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biograil with a free account
·The complete investor list: 11 names
·Watch Biograil: the Monday email on marks, rounds and moves
